Is TB-500 Legal in Michigan? How to Access It Legally
HealthRX.com
TB-500 has no federal approval or compounding listing
See the public record for TB-500
At a glance
- FDA approval / None in the US or countries FDA checked [1]
- Compounding lists / Not on the pharmacy list or the outsourcing-facility list [2][3][4]
- Advisory committee / Voted to recommend listing July 23, 2026; advice only [7][5]
- HHS draft / Non-binding enforcement discretion for TB-500 acetate injection, October 2026 [5][6]
- Human data / FDA found no article reporting TB-500 given to a person [1]
- Sport / WADA prohibits at all times [8]
What TB-500 is
TB-500 is a synthetic seven-amino-acid fragment — residues 17 to 23 of the 43-amino-acid protein thymosin beta-4 — with a molecular weight of about 889 g/mol, N-acetylated at one end; it is not the full protein, and 'TB-500' is a common name, not an official drug name [1]. It appears to have been first synthesized in 2003; a veterinary preparation appeared in 2011, marketed to boost performance in horses and greyhounds [1].
Is it FDA-approved or compoundable?
FDA's July 2026 review found no USP or National Formulary monograph, no FDA-approved drug containing TB-500, and no listing in the European or Japanese pharmacopeias [1]. State-licensed pharmacies may compound only with a bulk substance on FDA's list, with a USP or NF monograph, or as a component of an approved drug; outsourcing facilities use a separate list [4][2][3]. TB-500 is on neither list (pharmacy list updated May 14, 2026; outsourcing list March 21, 2025) and the category 1 policy does not cover it [2][3][4]. It sits in the 'nominated but withdrawn' table of FDA's safety-risk page, not the active category 2 table [9]. FDA staff proposed against adding it in July 2026, citing no human data and no evidence of effectiveness for wound healing [1]. The advisory committee voted in favor on July 23, 2026; that vote is non-binding [7][5]. A draft HHS policy filed October 28, 2026 names TB-500 acetate for injection but is not binding and does not put it on any list [5][6].
Questions worth asking
What is known about effectiveness and safety?
FDA found no article in which TB-500 was given to a person, and there is no approved dose or human dosing study [1]. In a laboratory scratch-wound test, TB-500 at 50 microgram/mL did not induce wound closure in fibroblast cultures [1]. Safety in humans is unknown: FDA's adverse-event database search through March 26, 2025 retrieved no TB-500 reports, and its food and supplement complaint system retrieved two cases about a blended TB-500 and BPC-157 product with no safety assessment [1]. FDA's stated concern for injectable TB-500 is immunogenicity, potentially amplified by aggregation and impurities [1].
Is it banned in sport?
WADA's Prohibited List names 'Thymosin-beta4 and its derivatives e.g. TB-500' in S2.3 and prohibits it at all times, in and out of competition; it remains on the 2027 List [8][10].
Check what you know
Question 1 of 3
Score: 0 right, 0 of 3 answered
Frequently asked questions
Is TB-500 legal in Michigan?
Can a Michigan pharmacy compound TB-500?
Is TB-500 the same as thymosin beta-4?
Has TB-500 been tested in people?
Reader questions
What people actually ask
Short answers drawn from the sources this article cites.
What are the new laws for 2026 in Michigan?
There is no verified information on Michigan state law, so what new 2026 Michigan laws apply cannot be stated. The 2026 federal actions described are not binding: an FDA advisory committee voted to recommend listing TB-500 on July 23, 2026, and a draft HHS policy filed October 28, 2026 names TB-500 acetate for injection but does not put it on any list.
Can a doctor prescribe peptides?
Whether doctors can prescribe peptides in general is not covered. One case is covered: a draft HHS policy filed October 28, 2026 says HHS does not intend to take enforcement action against certain licensed pharmacies and physicians compounding TB-500 acetate for injection if conditions are met. This is not an approval and does not make TB-500 an approved drug.
References
Show all 10 referencesHide references
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- U.S. Food and Drug Administration.
- Bulk Drug Substances Used in Compounding of the FD&C Act | FDA.
- Official web page.
- Official web page.
- U.S. Food and Drug Administration.
- World Anti-Doping Agency.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- World Anti-Doping Agency.